The Rosetrees Trust Major Project Awards fund translational research that moves an innovative idea closer to patients. Your project needs existing proof-of-concept data, including data generated by your own team, and a defined translational milestone to reach within the grant period. Preliminary applications are open now and close at 4pm on Monday 18 January 2027.
Awards are now worth up to £250,000, up from £210,000 when this scheme was last listed here in 2024. If your idea is at an earlier stage, Rosetrees points you towards its Seedcorn Awards instead.
What the award covers
- Up to £250,000 over three years, capped at £84,000 a year
- Salaries for postdoctoral research associates, technicians and research assistants (PhD stipends are only considered in exceptional cases)
- Consumables, sequencing, animal costs and other operational expenses
- Small equipment may be considered, but the grant can’t be used just to buy large capital equipment
You must include matched funding towards the directly incurred costs, either as direct financial support or in kind. As Rosetrees gets more fundable applications than it can support, it’s worth being careful with your costings.
Who can apply
The principal applicant will usually hold a tenured post, or be able to show their salary is covered for the lifetime of the grant. You must hold a PhD (or equivalent) and have a track record of managing grants, delivering research studies and publishing.
What your project needs
- Proof-of-concept data: including data generated by the applicant team
- An unmet clinical need: affecting a significant patient population in the UK. Rare disease projects can apply if they show relevance to wider patient groups
- A concrete next step: what happens after the grant, such as a clinical trial, a regulatory submission, follow-on funding, an industry partnership or adoption in the NHS
Applicants choose one of two routes: new approaches to major health challenges, or new applications of existing solutions.
What won’t be funded
- Discovery research without a translational endpoint
- Projects without proof-of-concept data
- Building cohorts or biobanks without a clinical question
- Continuation work without a new deliverable
- Large capital equipment
AI-based projects
There is separate guidance on the call page for projects using AI, covering the clinical use case, why AI is needed, data, validation, implementation, barriers and the team, along with a list of AI projects that are out of scope. As a member of the AMRC, Rosetrees also follows the Research Funders Policy Group joint statement on generative AI in applications.
Key dates
- Preliminary applications open: 9 November 2026
- Preliminary applications close: 4pm, Monday 18 January 2027
- Full applications (shortlisted applicants only): March to April 2027
- Outcome: October 2027
How applications are reviewed
Preliminary applications get an eligibility check and are then triaged by an internal scientific panel. Only a small proportion are invited to submit a full application, which goes out for external peer review before trustee approval, and some applicants may be interviewed. Rosetrees doesn’t give feedback on preliminary applications that aren’t shortlisted, so it pays to put real work into building a strong application from the first stage.
How to apply
Apply through the Rosetrees Flexigrant portal. Check the FAQs before getting in touch. For eligibility and application questions, contact Richard Miller at rmiller@rosetrees.org.uk. For general enquiries, email info@rosetrees.org.uk or call 0208 951 2588.
Visit funding web page
(https://rosetrees.org.uk/project_awards/)
